BioRegenx restates Q1 2024 financials; appoints Weinberg & Co. as new auditor

BIOREGENX, INC.

Engaged Weinberg & Company as new independent accountant for fiscal years ended Dec 31, 2023 and 2022, effective June 10, 2024.
Concluded Q1 2024 Form 10-Q and 10-Q/A should no longer be relied upon due to lack of auditor review prior to filing.
Management evaluating restatement impact on financials and internal controls; will file amended 10-Q/A as soon as practical.
No prior consultations with Weinberg on accounting principles or disagreements during past two fiscal years and subsequent interim period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.